APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5]

TUNG-HUNG SUJIA-HORNG KAODING-SHINN CHEN2021-03-092021-03-0920070270-9139https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250322231&doi=10.1002%2fhep.21575&partnerID=40&md5=b8e88746fafce9aade968c0c83ce0e87https://scholars.lib.ntu.edu.tw/handle/123456789/551152[SDGs]SDG3interferon; ribavirin; antiviral therapy; disease course; drug tolerance; hepatitis B; Hepatitis B virus; human; letter; liver fibrosis; long term care; priority journal; survival; treatment outcome; treatment response; Antiviral Agents; Aspartate Aminotransferases; Hepatitis C, Chronic; Humans; Interferons; Platelet Count; Predictive Value of TestsAPRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5]letter10.1002/hep.21575175389392-s2.0-34250322231